SEC Form 4/A · accession 0001610950-17-000048
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gregory S Rush
Officer — Chief Financial Officer
Period of report
Aug 30, 2017
Accepted (ET)
Sep 5, 2017 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Aug 30, 2017 | M | 35,503 | $10.06 | A | 113,799 | D | |
| Class A Common StockF3 | Aug 30, 2017 | S | 35,503 | $58.27 | D | 78,296 | D | |
| Class A Common Stock | Aug 30, 2017 | M | 5,917 | $16.06 | A | 84,213 | D | |
| Class A Common StockF4 | Aug 30, 2017 | S | 5,917 | $58.217 | D | 78,296 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F5 | $10.06 | Aug 30, 2017 | M | 35,503 | D | — | Aug 30, 2023 | Class A Common Stock | 35,503 | 71,005 | D |
| Stock Option (Right to Buy Class A Common Stock)F5 | $16.06 | Aug 30, 2017 | M | 5,917 | D | — | Jun 30, 2024 | Class A Common Stock | 5,917 | 23,668 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2016.
- F2This amendment was filed to correct the code in column 4 from D to A for the exercise.
- F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $57.60 to $58.52, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $57.85 to $58.45, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5The shares subject to this option vested on August 1, 2017.